A new trading day began on Friday, with Perspective Therapeutics Inc (AMEX: CATX) up 25.91% from the previous day of trading, before settling in for the closing price of $3.86. CATX’s price has ranged from $1.60 to $13.35 over the past 52 weeks.
During the last 5-year period, the sales drop of Healthcare Sector giant was -9.86%. Meanwhile, its annual earnings per share averaged 3.47%. With a float of $60.73 million, this company’s outstanding shares have now reached $74.26 million.
Perspective Therapeutics Inc (CATX) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Medical Devices Industry. The insider ownership of Perspective Therapeutics Inc is 18.23%, while institutional ownership is 66.79%. The most recent insider transaction that took place on Mar 28 ’25, was worth 49,384. In this transaction Chief Executive Officer of this company bought 22,026 shares at a rate of $2.24, taking the stock ownership to the 59,383 shares. Before that another transaction happened on Mar 28 ’25, when Company’s Chief Executive Officer bought 4,650 for $2.21, making the entire transaction worth $10,288. This insider now owns 4,650 shares in total.
Perspective Therapeutics Inc (CATX) Earnings and Forecasts
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.21 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.35 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 3.47% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -1.19% during the next five years compared to -9.86% drop over the previous five years of trading.
Perspective Therapeutics Inc (AMEX: CATX) Trading Performance Indicators
Here are Perspective Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 15.09. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 291.06.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.32, a number that is poised to hit -0.32 in the next quarter and is forecasted to reach -1.32 in one year’s time.
